20 Jun SMOKING STUDY INTERVIEW | THE ATLANTIC
Here's a video from The Atlantic Montlhy about the study at Johns Hopkins using psilocybin for treating long-term smokers. ...
Blog
18 Jun LIVE EVERY DAY LIKE YOU’RE ON MUSHROOMS | THE ATLANTIC
Psilocybin may help smokers quit the habit by giving them a mystical experience, according to an article in The Atlantic Monthly. In a Heffter-supported study at Johns Hopkins University, 12 of 15 subjects quit smoking after three sessions with the psychedelic substance. Lead researcher Dr....
16 Apr Heffter President David Nichols On 50 Years Of Research
Please join Heffter Research Institute President and co-founder David Nichols for his presentation “Nearly Half a Century Studying Psychedelics,” an overview of his pioneering career in the field of psychedelic research. Dr. Nichols will appear at 7:00 PM on Saturday, April 30th, at the California Institute...
12 Apr BRAIN ON LSD REVEALED | SCIENCEDAILY
A team of researchers at Imperial College London produced the first images of the human brain under the influence of LSD. According to ScienceDaily, 20 healthy volunteers received 75 micrograms of LSD. The research team, led by Dr. Robin Carhart-Harris, used advanced imaging technology to study...
16 Dec HALLUCINOGENS COULD HOLD KEY TO QUITTING SMOKING | ATTN
A pioneering study by Heffter researcher Matthew Johnson continues to draw attention in the media. A story in the online magazine ATTN covers Johnson’s research on the use of psilocybin for treating nicotine addiction. Writer Kyle Jaeger compares the success rate in Johnson’s study, in which...
08 Dec ONE HIT WONDER | APA MONITOR ON PSYCHOLOGY
A feature article in the December 2015 issue of Monitor on Psychology, a publication of the American Psychological Association, surveys recent developments in psychedelic science with an emphasis on Heffter-sponsored research. In “One Hit Wonder,” writer Kirsten Weir quotes Heffter researchers Roland Griffiths, Anthony Bossis, and Jeffrey Guss....
20 Nov A NEW UNDERSTANDING: THE SCIENCE OF PSILOCYBIN
A documentary film titled A New Understanding: The Science of Psilocybin explores the use of psilocybin as a treatment for cancer patients. “The film presents an intimate look into the lives of several terminally ill cancer patients participating in the studies, and opens an intriguing discourse of...
04 Aug NEW STUDY LINKS NEURAL ACTIVITY WITH PSILOCYBIN-INDUCED SPIRITUAL EXPERIENCES
New research by a team including Heffter board member Franz Vollenweider casts light on the well-known but little understood ability of psychedelics to produce spiritual experiences. The study, published in the journalPsychopharmacology, involved EEG recordings of 50 healthy volunteers who took a moderate dose of psilocybin....
27 May DEEP DIVE: YOUR BRAIN ON PSYCHEDELICS/SPIRITUALITY | HUFFPOST LIVE
A new episode of Deep Dive, a series on HuffPost Live devoted to drugs and religion, features interviews with two Heffter researchers–Roland Griffiths and Franz Vollenweider. Among other topics, Dr. Griffiths describes his pioneering research on psilocybin and mystical experience. Dr. Vollenweider offers insights on...
11 May RESEARCHERS DISCUSS PILOT STUDY ON HALLUCINOGENIC THERAPIES FOR CANCER ANXIETY | THE ASCO POST
An article in The ASCO Post, the online newsletter of the American Society of Clinical Oncology, discusses an important study sponsored by the Heffter Research Institute. Writer Ronald Piana describes the work of Heffter scientists Steven Ross, Anthony Bossis, and Jeffrey Guss, who are using psilocybin to...